EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Perioperative Outcomes of Robotic Radical Prostatectomy with Hugo™ RAS versus daVinci Surgical Platform: Propensity Score-Matched Comparative Analysis

Carlo Gandi iD, Filippo Marino iD, Angelo Totaro, Eros Scarciglia, Fabrizio Bellavia, Riccardo Bientinesi, Filippo Gavi iD, Pierluigi Russo iD, Mauro Ragonese iD, Giuseppe Palermo iD, Marco Racioppi iD, Nicolò Lentini iD und 2 weitere

Journal of Clinical Medicine · 28.05.2024 · 13 (11) · 3157

DOI: 10.3390/jcm13113157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 28.05.2024. Verfasst von Carlo Gandi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: There is an urgent need for comparative analyses of the intraoperative, oncological, and functional outcomes of different surgical robotic platforms. We aimed to compare the outcomes of RARP performed at a tertiary referral robotic centre with the novel HugoTM RAS system with those performed with a daVinci surgical system, which is considered the reference standard.

Methods

We analysed the data of 400 patients undergoing RARP ± pelvic lymph node dissection between 2021 and 2023, using propensity score (PS) matching to correct for treatment selection bias. All procedures were performed by three surgeons with HugoTM RAS or daVinci.

Results

The PS-matched cohort included 198 patients with 99 matched pairs, balanced for all covariates. Positive surgical margins (PSMs) were found in 22.2% and 25.3% (p = 0.616) of patients, respectively, in the HugoTM RAS and daVinci groups. No significant differences were found for other important perioperative outcomes, including median (1st–3rd q) operative time (170 (147.5–195.5) vs. 166 (154–202.5) min; p = 0.540), median (1st–3rd q) estimated blood loss (EBL) (100 (100–150) vs. 100 (100–150) ml; p = 0.834), Clavien–Dindo (CD) ≥ 2 complications (3% vs. 4%; p = 0.498), and social continence at 3 months (73.7% vs. 74.7%; p = 0.353). In multiple analyses, no associations were found between surgical outcomes (PSM, length of PSM, operative time, EBL, length of catheterization, length of hospital stay, social continence at three months after surgery, and CD ≥ 2 complications) and the robotic platform.

Conclusions

Our findings demonstrate that HugoTM RAS enables surgeons to safely and effectively transfer the level of proficiency they reached during their previous experience with the daVinci systems.

Schlagwörter

Stichwörter der Autor:innen

HugoTM RAS systemcomparative outcomesdaVinci surgical platformprostate cancerrobot-assisted radical prostatectomyrobotic surgery

Autor:innen und Institutionen

  • Department of Urology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
  • Department of Medicine and Translational Surgery, Università Cattolica Del Sacro Cuore, 00168 Rome, Italy.
  • Department of Urology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
  • Department of Life Sciences and Public Health, Section of Hygiene, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
  • Department of Woman and Child Health and Public Health-Public Health Area, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
  • Department of Urology, Ospedale Isola Tiberina-Gemelli Isola, 00168 Rome, Italy.

ORCID-Profile: Carlo Gandi, Filippo Marino, Filippo Gavi, Pierluigi Russo, Mauro Ragonese, Giuseppe Palermo, Marco Racioppi, Nicolò Lentini, Emilio Sacco

Zitieren

APA

Gandi, C., Marino, F., Totaro, A., Scarciglia, E., Bellavia, F., Bientinesi, R., Gavi, F., Russo, P., Ragonese, M., Palermo, G., Racioppi, M., Lentini, N., Pastorino, R., & Sacco, E. (2024). Perioperative Outcomes of Robotic Radical Prostatectomy with Hugo™ RAS versus daVinci Surgical Platform: Propensity Score-Matched Comparative Analysis. Journal of Clinical Medicine, 13(11), 3157. https://doi.org/10.3390/jcm13113157

Vancouver

Gandi C, Marino F, Totaro A, Scarciglia E, Bellavia F, Bientinesi R, et al. Perioperative Outcomes of Robotic Radical Prostatectomy with Hugo™ RAS versus daVinci Surgical Platform: Propensity Score-Matched Comparative Analysis. Journal of Clinical Medicine. 2024;13(11):3157. doi:10.3390/jcm13113157

BibTeX
@article{Gandi2024,
  author = {Gandi, Carlo and Marino, Filippo and Totaro, Angelo and Scarciglia, Eros and Bellavia, Fabrizio and Bientinesi, Riccardo and Gavi, Filippo and Russo, Pierluigi and Ragonese, Mauro and Palermo, Giuseppe and Racioppi, Marco and Lentini, Nicolò and Pastorino, Roberta and Sacco, Emilio},
  title = {Perioperative Outcomes of Robotic Radical Prostatectomy with Hugo™ RAS versus daVinci Surgical Platform: Propensity Score-Matched Comparative Analysis},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {11},
  pages = {3157},
  doi = {10.3390/jcm13113157}
}
Kostenlos starten →